Overview of the Company
As a Japanese-owned enterprise invested and established by Japan Alps Pharmaceutical Ind. Co., Ltd. and Japan Longtai Trading Co., Ltd. on August 30, 1994, Qingdao Tai Tong Pharmaceutical Co., Ltd. now has registered capital of USD 6.75 million, and actual aggregate investment of USD 15 million.
The company is in northern Qingdao, China and by the side of the Yellow Sea, only 5km from Qingdao Airport where the lines reach every part of the world; it only takes 30min for the company’s goods to reach Qingdao container terminal from which the goods can directly reach each European and American base port.
The company is the largest manufacturer of rutin in the world, which has been produced for above 66 years since first produced in Japan in 1951. During the period, the company’s “Rutin” brand has achieved stable and long-term development thanks to the support and consideration of the new and old customers from China and foreign countries. The company started to conduct formal production and operation as the largest and most advanced professional manufacturer of rutin in China since April 26, 1996 after over 1 year of construction in Qingdao, China.
The company faces the world market based on the rich medicinal materials and plant resources in China and depending on the advanced extractive technique and management level, and has achieved much development in recent years, from originally the professional manufacturer of rutin APIs to a comprehensive plant extract manufacturer of APIs, food additives, pharma intermediates, and cosmetics raw materials.
- Product Content
Rutin—With raw material from natural ingredients of the natural plant Chinese scholar tree, rutin is produced upon extraction and refinement. The company has established stable raw material supply channels in China and Vietnam over the years, to guarantee the stability of rutin production. Rutin can contract capillaries, can be used in hemostatic, can be used to treat and prevent cerebral hemorrhage and hypertension, and can also be used in pharmaceutical products and health products for diseases of capillaries. Experimental research in recent years has discovered that it can also be used in sunscreen cosmetics. The product of the company is mainly used as raw material of water soluble rutin, and sold to European countries and Japan.
The company can produce 500 tons of rutin every year, with large extracting devices working continuously for 24h to handle over 10 tons of raw materials every day. The product has been scientifically verified for years, and is produced through extraction →filtration →concentration →crystallization →centrifugation →drying →smash →mixing →packaging, etc. Processes from centrifugation onwards are carried out in a class 300,000 clean area, to guarantee the rutin product quality and stability at the production stage.
Rhamnose—With the natural ingredients extracted from the unique natural plant—fructus aurantii immaturus in China as the raw material, the product is being widely applied worldwide such as the Europe as a natural ingredient of food flavors and cosmetic perfume. Its medicinal value has been developed vigorously recently in the U.S., and its future applications in the field of medicine are worth expecting. The product is made through hydrolytic decomposition →fermentation. The company can produce 100 tons every year.
Radix glycyrrhizae products—They are refined from the natural plant—radix glycyrrhizae, have good effects like anti-inflammation and liver function protection, and are widely applied in pharmaceutical industry, cosmetics industry, and food industry, etc. In the medical aspect, the products are widely applied in anti-inflammatory drugs for external use and drugs for patients with liver disease; the products are also generally applied in cosmetics and shampoo, etc. owing to the anti-inflammatory effect in skin. The products are mainly monoammonium glycyrrhizinat...
(All Rights Reserved)